Elemental Diet for Inflammatory Bowel Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if an elemental diet, a special liquid diet, can benefit individuals with chronic granulomatous disease (CGD) and inflammatory bowel disease (IBD) by altering the bacteria in their stomach and intestines. Researchers seek to discover if this diet can alleviate gastrointestinal symptoms such as stomach pain or diarrhea. Suitable candidates for this trial include those diagnosed with CGD or IBD who experience symptoms impacting their daily lives. Participants will follow the diet, specifically using Neocate Splash, for up to four weeks and will stay in the hospital for part of the time to monitor changes. As a Phase 2 trial, this research focuses on assessing the treatment's effectiveness in an initial, smaller group of people.
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. However, it mentions that active infections requiring antibiotics, other than known preventive medications, are excluded, which might imply some restrictions. It's best to discuss your specific medications with the trial team.
Is there any evidence suggesting that this treatment is likely to be safe for humans?
Research shows that Neocate Splash, the treatment being tested, is usually easy for people to handle. This special drink, made from amino acids, is unlikely to cause allergic reactions. Studies have found it safe for individuals with cow milk allergies and other food allergies. Most people do not experience serious side effects, though some might have mild issues like changes in bowel movements or stomach discomfort. Using Neocate Splash under a doctor's guidance is important to ensure safety and proper nutrition.12345
Why are researchers excited about this trial?
Neocate Splash is unique because it offers a nutritional approach to managing Inflammatory Bowel Disease (IBD) that differs from standard treatments like anti-inflammatory drugs, immunosuppressants, and biologics. Unlike these medications, which focus on reducing inflammation or modulating the immune system, Neocate Splash is an elemental diet. This means it provides easily digestible nutrients in their simplest form, which can be gentler on the digestive tract and potentially reduce symptoms without the side effects associated with medications. Researchers are excited about this treatment because it offers a non-pharmacological option that could improve patients' quality of life by minimizing gastrointestinal distress and promoting nutritional absorption.
What evidence suggests that this elemental diet is effective for inflammatory bowel disease?
Research has shown that special diets like Neocate Splash, which participants in this trial will follow, can help people with inflammatory bowel disease (IBD) by altering gut bacteria. Neocate Splash has been proven to reduce gut inflammation. In one study, 17 adults followed a similar diet for four weeks and experienced reduced inflammation. This diet replaces regular food with a liquid formula that provides all necessary nutrients. Consequently, it can improve digestive symptoms by supporting healthier gut bacteria.34678
Who Is on the Research Team?
Christa S Zerbe, M.D.
Principal Investigator
National Institute of Allergy and Infectious Diseases (NIAID)
Are You a Good Fit for This Trial?
This trial is for people aged 8-65 with Chronic Granulomatous Disease (CGD) and Inflammatory Bowel Disease (IBD). They should have certain levels of disease activity, be willing to stay in the hospital for up to two weeks, and consent to genetic testing. Pregnant individuals or those with conditions that make participation unsafe are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are put on a special elemental diet for up to 4 weeks, with inpatient stay for up to 2 weeks
Follow-up
Participants have 2 follow-up visits to monitor changes in microbiome and reintroduce normal food
What Are the Treatments Tested in This Trial?
Interventions
- Neocate Splash
Find a Clinic Near You
Who Is Running the Clinical Trial?
National Institute of Allergy and Infectious Diseases (NIAID)
Lead Sponsor